Literature DB >> 17087120

Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones.

B Hinz1, K Brune.   

Abstract

Antipyretic analgesics are a group of heterogeneous substances including acidic (nonsteroidal antiinflammatory drugs, NSAIDs) and nonacidic (paracetamol, pyrazolinones) drugs. Moreover, various selective cyclooxygenase-2 (COX-2) inhibitors with improved gastrointestinal tolerability as compared with conventional NSAIDs have been established for symptomatic pain treatment in recent years. The present review summarizes the pharmacology of all of these drugs with particular emphasis on their rational use based on the diverse pharmacokinetic characteristics and adverse drug reaction profiles. Referring to the current debate, potential mechanisms underlying cardiovascular side effects associated with long-term use of COX inhibitors are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17087120     DOI: 10.1007/978-3-540-33823-9_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  10 in total

1.  Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4.

Authors:  Qingsong Wang; Yuhu He; Yujun Shen; Qianqian Zhang; Di Chen; Caojian Zuo; Jing Qin; Hui Wang; Junwen Wang; Ying Yu
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

Review 2.  Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy.

Authors:  Timothy D Warner; Sven Nylander; Carl Whatling
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

3.  Strategies Aimed at Preventing Chronic Post-surgical Pain: Comprehensive Perioperative Pain Management after Total Joint Replacement Surgery.

Authors:  Hance Clarke; Linda J Woodhouse; Deborah Kennedy; Paul Stratford; Joel Katz
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

Review 4.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

5.  Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.

Authors:  T M Cunha; M M Barsante; A T Guerrero; W A Verri; S H Ferreira; F M Coelho; R Bertini; C Di Giacinto; M Allegretti; F Q Cunha; M M Teixeira
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

6.  Effects of a single paracetamol injection on the sevoflurane minimum alveolar concentration in dogs.

Authors:  Paula González-Blanco; Susana Canfrán; Rubén Mota; Ignacio A Gómez de Segura; Delia Aguado
Journal:  Can J Vet Res       Date:  2020-01       Impact factor: 1.310

7.  [From willow bark to the coxibs. Development of antiphlogistic analgesics].

Authors:  K Brune; U Niederweis
Journal:  Schmerz       Date:  2007-08       Impact factor: 1.629

Review 8.  CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.

Authors:  Patrizia Bonelli; Franca Maria Tuccillo; Antonella Borrelli; Antonietta Schiattarella; Franco Maria Buonaguro
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

9.  Resolution of five-component mixture using mean centering ratio and inverse least squares chemometrics.

Authors:  Mahmoud Mohamed Issa; R'afat Mahmoud Nejem; Alaa Mohamed Abu Shanab; Nahed Talab Shaat
Journal:  Chem Cent J       Date:  2013-09-12       Impact factor: 4.215

Review 10.  Use of NSAIDs in treating patients with arthritis.

Authors:  Leslie J Crofford
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.